Transpact Enterprises Ltd
₹190.35▼ -10.00 (-4.99%)
TRANSPACTENTERPRISESLTD·NSE·Healthcare
Market Cap
3.30 Cr
PE Ratio
732.12
Volume
1,000
Day High - Low
198.00 - 190.35
52W High-Low
206.70 - 190.35
₹190.35▼ -10.00 (-4.99%)
Market Cap3.30 Cr
PE Ratio732.12
Volume1,000
Day High - Low198.00 - 190.35
52W High-Low206.70 - 190.35
Transpact Enterprises Ltd (TRANSPACTENTERPRISESLTD): company summary
Transpact Enterprises Ltd (TRANSPACTENTERPRISESLTD) is a micro-cap Healthcare company valued at ₹3 crore operating in Medical Equipment on the NSE and BSE.
Transpact Enterprises Ltd (TRANSPACTENTERPRISESLTD) is a micro-cap Healthcare company valued at ₹3 crore operating in Medical Equipment on the NSE and BSE.
- Recent price move
- Transpact Enterprises Ltd last traded at ₹190.35, down 4.99% on the day.
- Financial performance
- Revenue has been shrinking at -22.1% a year over three years. Return on equity is 18.4%.
- Valuation multiples
- The stock trades at 732.1 times earnings, a premium to the Healthcare median of 32.0, 6.20 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Last traded ₹190.35 on 18 Jun 2026 (121 days ago). Not a live price.
DocStoX Score
3.5/10
Poor
Fair Value
Sign in to see
ROE
18.40%
Strong
P/E
732.12x
Expensive
Debt / Equity
0.11
Low
Industry
Healthcare
Medical Equipment
Overall View
Mixed
Price performance
Day₹190.35
₹198.00
52W₹190.35
₹206.70
DocStoX take
Supported by growth (7.5), but held back by momentum (0.0). Growth looks strong at 7.5, but that is offset by valuation at 0.0 and momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence3.5
/10
Poor
Quality
Modest
ROE 18.4%
Valuation
Expensive
P/E 200.0×
Growth
Strong
Revenue +43.1% 5Y CAGR
Risk
Moderate
D/E 0.11
Momentum
Weak
0% of 52-week range
At a glance
Market Cap
₹3 Cr
52W High / Low
₹207 / ₹190
Dividend Yield
0.00%
Promoter Holding
16.16%
EPS (TTM)
₹0.26
Book Value
₹13.88
Key highlights
- Revenue compounding 43% a year
- Low leverage — D/E 0.11
- Strong returns on equity (18%)
- Loss-making in some of the last 5 years
- Valuation is weak (0.0/10)
3 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Medical Equipment
Explore Transpact Enterprises Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Transpact Enterprises Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Transpact Enterprises Ltd with peers
Transpact Enterprises Ltd vs Sun Pharmaceutical Industries LimitedTranspact Enterprises Ltd vs Divi's Laboratories LimitedTranspact Enterprises Ltd vs Torrent Pharmaceuticals LimitedTranspact Enterprises Ltd vs Apollo Hospitals Enterprise LimitedTranspact Enterprises Ltd vs Zydus Lifesciences LimitedTranspact Enterprises Ltd vs Laurus Labs Limited
Related tools & concepts
Value Transpact Enterprises Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing